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Abstract
Introduction:  Cardiovascular  disease  is  an  important  cause  of  death  and  disability  worldwide,
and hypertension  is  responsible  for  at  least  45%  of  all  deaths  due  to  heart  disease  and  51%  of
deaths due  to  stroke.  This  study  aimed  to  estimate  and  describe  the  distribution  of  prevalence,
awareness,  treatment  and  control  of  hypertension  in  the  Portuguese  population  in  2015.
Methods: A  national  survey  using  a  representative  sample  of  4911  individuals  residing  in  Por-
tugal and  aged  between  25  and  74  years  was  implemented.  Trained  nurses  performed  a  health
interview and  a  physical  examination,  including  blood  pressure  measurement  (right  arm,  three
measurements  at  1-min  intervals).  The  prevalence  of  hypertension  was  stratiﬁed  by  gender,
age group,  marital  status,  education,  occupation  and  type  of  residential  area.  Associations
between  hypertension  prevalence  and  sociodemographic  factors  were  assessed  using  bivariate
and multivariate  Poisson  regression.∗ Corresponding author.
E-mail address: ana.rodrigues@insa.min-saude.pt (A.P. Rodrigues).
1 The names of the member of the INSEF Research group are listed in Appendix A.
https://doi.org/10.1016/j.repc.2018.10.012
0870-2551/© 2019 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Results:  The  overall  hypertension  prevalence  was  36.0%.  The  highest  rates  were  observed  in
males (39.6%),  in  individuals  aged  between  65  and  74  years  (71.3%),  and  in  those  with  low  levels
of education  (62.6%)  and  with  no  formal  occupation  (64.5%).  Among  hypertensive  individuals,
69.8% were  aware  of  their  condition  and  69.4%  were  under  treatment,  of  whom  71.3%  were
controlled.  Rates  of  awareness  and  medical  treatment  were  signiﬁcantly  higher  among  women
and older  individuals.
Conclusions:  A  large  majority  of  the  adult  Portuguese  population  are  likely  to  reach  blood
pressure levels  deﬁned  as  hypertension  in  adulthood.  Signiﬁcant  differences  in  hypertension
prevalence  were  found  according  to  gender,  age  and  socioeconomic  status,  which  highlights
the importance  of  population  strategies  in  public  health  policies.
© 2019  Sociedade  Portuguesa  de  Cardiologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Disparidades  sociodemográﬁcas  da  prevalência  de  hipertensão:  resultados  do
primeiro  Portuguese  Health  Examination  Survey
Resumo
Introduc¸ão: As  doenc¸as  cardiovasculares  são  uma  importante  causa  de  morte  e  incapacidade,
sendo que  a  hipertensão  arterial  (HTA)  é  responsável  por,  pelo  menos,  45%  da  mortalidade
por doenc¸a  cardíaca  e  51%  por  acidente  vascular  cerebral.  Este  estudo  pretende  estimar  e
descrever a  distribuic¸ão  da  prevalência,  awareness,  tratamento  e  controlo  da  HTA  na  populac¸ão
portuguesa  em  2015.
Métodos:  Realizou-se  um  inquérito  nacional  com  uma  amostra  representativa  de  4911  indiví-
duos, dos  25  aos  74  anos,  residentes  em  Portugal,  e  que  compreendia  a  realizac¸ão  de  uma
entrevista de  saúde  e  exame  físico  que  incluía  a  medic¸ão  da  pressão  arterial  (brac¸o  direito,
três medidas,  intervalos  de  um  minuto).  A  prevalência  de  HTA  foi  estratiﬁcada  por  sexo,  grupo
etário, estado  civil,  educac¸ão,  ocupac¸ão  e  nível  de  urbanizac¸ão.  Estimou-se  a  associac¸ão  entre
a HTA  e  os  fatores  sociodemográﬁcos  usando  regressão  de  Poisson  bivariada  e  multivariada.
Resultados:  A  prevalência  de  HTA  foi  de  36,0%,  sendo  mais  elevada  em  indivíduos  do  sexo
masculino (39,6%),  entre  os  65  e  74  anos  (71,3%),  com  baixo  nível  de  escolaridade  (62,6%)  e
sem ocupac¸ão  formal  (64,5%).  Dos  indivíduos  hipertensos,  69,8%  tinham  conhecimento  da  sua
condic¸ão de  saúde,  69,4%  faziam  medicac¸ão  anti  hipertensora  e,  destes,  71,3%  estavam  con-
trolados. A  prevalência  do  conhecimento  e  tratamento  farmacológico  da  HTA  foi  mais  elevada
em mulheres  e  indivíduos  mais  velhos.
Conclusões:  A  maioria  da  populac¸ão  adulta  portuguesa  poderá  vir  a  ter  HTA  ao  longo  da  vida.
Foram encontradas  diferenc¸as  importantes  na  prevalência  de  HTA  de  acordo  com  o  sexo,  a
idade e  o  nível  socioeconómico,  o  que  enfatiza  a  importância  de  estratégias  populacionais  nas
políticas de  saúde  pública.
© 2019  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este e´ um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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ardiovascular  disease  is  the  leading  global  cause  of  death
nd  disability,  causing  about  17  million  deaths  per  year,
bout  a  third  of  all  deaths  worldwide.  Of  these,  9.4  mil-
ion  deaths  are  due  to  hypertension-related  complications.1
ypertension  is  an  important  risk  factor  for  developing  car-
iovascular  disease,  and  is  estimated  to  be  responsible  for
t  least  45%  of  all  deaths  due  to  heart  disease  and  51%  of
2eaths  due  to  stroke.
Epidemiological  studies  suggest  that  there  is  a  continu-
us  increase  in  the  risk  of  developing  cardiovascular  disease,
troke  and  kidney  disease  with  increasing  systolic  (SBP)  and
p
i
y
miastolic  (DBP)  blood  pressure  levels.3,4 In  2008,  approxi-
ately  40%  of  adults  aged  over  25  years  worldwide  had
een  diagnosed  with  hypertension.5 In  Europe,  the  European
ealth  Examination  Survey  (EHES)  Pilot  Project  reported  a
ypertension  prevalence  of  33.1%  among  men  and  22.8%
mong  women  (aged  25-64  years),  although  with  consid-
rable  variation  in  blood  pressure  measurements  between
ifferent  populations.6
In  Portugal,  high  hypertension  prevalences  have  been
7,8reviously  reported  for  the  general  population. Two  stud-
es,  representative  of  the  Portuguese  population  (aged  18-90
ears,  Portuguese  mainland),  which  included  blood  pressure
easurement,  have  been  performed:  one  in  2003  (the  PAP
RA
l
O
e
t
p
c
D
T
c
p
o
a
s
f
v
d
a
p
m
t
a
i
s
a
t
f
p
T
l
p
r
a
a
s
w
M
T
s
t
1
h
(
aSociodemographic  disparities  in  hypertension  prevalence  
study),  which  reported  a  prevalence  of  42.1%,9 and  the  other
in  2011-2012  (the  PHYSA  study),10 in  which  the  prevalence
was  42.2%.  In  2014,  the  ﬁfth  Portuguese  National  Health  Sur-
vey  estimated  a  lower  prevalence  of  hypertension  (24.5%),
but  this  was  based  on  the  Portuguese  population  over  15
years  old  and  on  self-reported  data.11
Monitoring  hypertension  prevalence  in  the  Portuguese
population  is  essential  for  public  health  planning,  especially
for  the  deﬁnition  of  health  strategies  in  primary  prevention,
such  as  nutrition  policies,  and  also  hypertension  manage-
ment,  resource  allocation  and  appraisal  of  health  programs.
Moreover,  indicators  of  availability  of  and  compliance  with
appropriate  treatment  (prevalence  of  individuals  who  are
aware  of  their  condition,  are  being  treated  and  have  hyper-
tension  under  control)  also  need  to  be  nationally  monitored,
which  will  help  public  health  professionals  to  tailor  strate-
gies  of  hypertension  prevention  for  high-risk  individuals.
Given  this  context,  the  aim  of  this  study  was  ﬁrstly
to  estimate  and  describe  the  distribution  of  hypertension
prevalence  in  the  Portuguese  population  in  2015,  and  sec-
ondly  to  estimate  the  distribution  of  awareness,  treatment
and  control  of  hypertension.
Methods
The  2015  Portuguese  National  Health  Examination  Survey
(INSEF)  was  a  cross-sectional  population-based  study  by  the
National  Health  Institute  Doutor  Ricardo  Jorge  (INSA)  in
cooperation  with  the  ﬁve  Regional  Health  Administrations,
the  two  Regional  Health  Secretariats  of  the  Autonomous
Regions  of  the  Azores  and  Madeira,  and  the  Norwegian  Insti-
tute  of  Public  Health.12
Target  population
The  INSEF  target  population  was  non-institutionalized  indi-
viduals  aged  between  25  and  74  years,  resident  in  Portugal
for  more  than  12  months,  and  able  to  follow  an  interview  in
Portuguese.
Sampling
Sampling  was  based  on  a  two-stage  probabilistic  strati-
ﬁed  cluster  design.  The  national  territory  was  divided  into
386  primary  sampling  units  (PSUs),  corresponding  to  the
catchment  areas  of  the  health  centers.  The  PSUs  were  strati-
ﬁed  by  region  and  by  type  of  residential  area,  with  allocation
proportional  to  the  population  weight.
In  the  ﬁrst  stage,  49  PSUs  (seven  per  region)  were
selected  with  selection  probability  proportional  to  pop-
ulation  size.  In  the  second  stage,  individuals  (secondary
sampling  units),  registered  users  of  the  National  Health  Sys-
tem,  were  selected  in  each  selected  PSU  by  simple  random
sampling.
The  minimum  sample  size  was  set  at  4200  individuals  at
national  level  in  order  to  estimate  the  expected  prevalence
of  50%  with  an  error  margin  of  ±5%  at  a  95%  conﬁdence  level,
assuming  a  design  effect  of  1.5.12 The  original  sample  size
was  inﬂated  to  12  289  individuals  to  account  for  differences
in  response  rates  expected  at  regional  level.
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ecruitment  of  participants
ll  the  selected  individuals  were  invited  to  participate  by
etter  two  weeks  prior  to  the  beginning  of  the  ﬁeldwork.
ne  week  later,  they  were  contacted  by  telephone  to  assess
ligibility  and  to  schedule  an  appointment  with  the  study
eam  in  their  health  center.  For  those  who  did  not  agree  to
articipate,  a  brief  questionnaire  concerning  various  health
onditions  and  behaviors  was  administered  by  telephone.12
ata  collection
he  survey  encompassed  core  physical  measurements,  blood
ollection  and  a health  interview.  The  INSEF  ﬁeldwork  took
lace  between  February  and  December  2015.
Health  professionals  who  had  completed  about  21  hours
f  training  on  all  survey  procedures  conducted  all  interviews
nd  examinations  in  health  center  facilities.
Information  on  sociodemographic  characteristics,  health
tatus,  disease  and  disability,  health  determinants  and  risk
actors,  preventive  health  care  and  use  of  health  care  ser-
ices,  including  medication  intake  and  self-reported  medical
iagnosis  of  hypertension,  was  collected  by  computer-
ssisted  personal  interview.
Blood  pressure  was  measured  according  to  the  EHES
rocedures13 using  an  automated  blood  pressure  measure-
ent  device  (Omron  M6).  Cuffs  were  selected  according  to
he  individual’s  arm  size  (M  for  arm  conference  ≤32  cm;  L  for
rm  conference  >32  cm).  All  participants  rested  for  5  min
n  a sitting  position  before  the  measurements.  Three  con-
ecutive  measurements  were  performed  on  the  right  arm
t  1-min  intervals.  Speciﬁc  medical  conditions  deﬁned  in
he  EHES  procedures13 were  considered  exclusion  criteria
or  blood  pressure  measurement.
Data  quality,  including  interobserver  variability  in  blood
ressure  measurement,  was  monitored  during  the  ﬁeldwork.
he  monitoring  included  checking  the  distribution  of  the
ast  digit  of  the  measures  and  also  the  mean  value  of  each
arameter  measured  by  nurse  and  instrument.12,13
For  the  purposes  of  this  study,  blood  pressure  was
ecorded  as  the  mean  of  the  second  and  third  readings  if
ll  three  readings  were  available,  or  the  mean  of  the  ﬁrst
nd  second  readings  if  the  third  reading  was  missing,  or  the
econd,  third  or  ﬁrst  reading  if  two  consecutive  readings
ere  missing.
easurements  and  deﬁnitions
he  deﬁnitions  proposed  for  the  EHES  were  used  for  this
tudy.14
Hypertension  prevalence  was  deﬁned  as  the  propor-
ion  of  individuals  among  all  survey  participants  with  SBP≥
40  mmHg  or  DBP≥90 mmHg  or  who  reported  taking  anti-
ypertensive  medication  two  weeks  before  the  interview
deﬁned  in  EHES  as  actual  or  potential  hypertension).
The  prevalence  of  awareness  of  hypertension  was  deﬁned
s  the  proportion  of  individuals  among  those  deﬁned  as
aving  hypertension  who  self-reported  hypertension,  as
iagnosed  by  a  physician.
The  prevalence  of  antihypertensive  drug  use  was  deﬁned
s  the  proportion  of  individuals  who  reported  taking
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ntihypertensive  medication  among  those  classiﬁed  as
aving  hypertension.
The  proportion  of  controlled  hypertension  was  deﬁned
s  the  proportion  of  individuals  with  SBP<140  mmHg  or  DBP<
0  mmHg  among  those  who  reported  taking  antihypertensive
edication  in  the  two  weeks  before  the  interview.
The  distribution  of  individuals  according  to  the  month
f  the  last  blood  pressure  measurement  by  a  physician  was
lassiﬁed  as  follows:  less  than  three  months;  3-5  months;
-11  months;  12  months  or  more.
tatistical  analysis
he  survey  response  rate  was  calculated  as  the  proportion  of
articipants  to  the  total  number  of  eligible  cases  and  cases
ith  unknown  eligibility.12
Means,  standard  deviations,  counts  and  percentages
ere  used  to  describe  study  participants.
Hypertension  prevalence  was  stratiﬁed  by  gender
female  or  male),  age  group  (25-44,  45-54,  55-64,  65-74
ears),  marital  status  (married  or  in  a  civil  union,  unmarried
single,  divorced,  separated  or  widowed]),  working  status
employed,  unemployed,  other  [student,  retired  or  home-
aker]),  educational  level  (no  formal  education  or  the  ﬁrst
ycle  [four  years]  of  basic  education,  second  or  third  cycle
six  or  eight  years]  of  basic  education,  secondary  educa-
ion,  higher  education)  and  type  of  residential  area  (urban
r  rural).  Associations  between  hypertension  and  sociode-
ographic  factors  were  assessed  by  crude  (PR)  and  adjusted
aPR)  prevalence  ratios  estimated  using  bivariate  and  mul-
ivariate  Poisson  regression  models,  respectively.  Poisson
egression  models  have  been  recently  identiﬁed  as  a bet-
er  choice  than  logistic  regression  models  for  cross-sectional
tudies  when  the  outcome  event  is  not  a  rare  one.15--17 All
ariables  found  to  be  signiﬁcant  in  bivariate  analyses  were
ntroduced  into  the  multiple  regression  models.
Awareness,  treatment  and  control  of  hypertension  were
lso  stratiﬁed  by  gender  and  age  group.
All  statistical  analyses  were  performed  using  sampling
eights  to  account  for  different  selection  probabilities
esulting  from  the  complex  sample  design  and  to  match  the
opulation  distribution  in  terms  of  geographic  region,  age
roup  and  gender.18
The  statistical  analysis  was  carried  out  using  [SVY]  in
tata® version  11  (College  Station,  TX).19 The  signiﬁcance
evel  for  all  analyses  was  set  at  5%.
thical considerations
he  INSEF  study  was  approved  by  the  Ethics  Committee
f  the  Portuguese  National  Health  Institute  Doutor  Ricardo
orge,  the  National  Data  Protection  Commission  (CNPD),  and
ight  regional  ethics  committees.  Written  informed  consent
as  obtained  from  all  participants  before  data  collection.esults
f  the  12  289  selected  individuals,  4911  participated  in
NSEF  2015,  leading  to  a  participation  rate  of  43.9%.  Only
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ne  individual  did  not  undergo  blood  pressure  measurement
ue  to  a  medical  condition.
The  participants’  characteristics  are  described  in
upplementary  Table  1.  Participants  were  mostly  married
r  in  a  civil  union  (68.4%),  of  working  age  (84.3%  aged
5-64  years);  27.7%  had  only  the  ﬁrst  cycle  or  no  education,
3.6%  lived  in  an  urban  area  and  61.9%  were  employed.
Mean  SBP  and  DBP  were  125.4  mmHg  (95%  conﬁdence
nterval  [CI]:  124.3-126.3;  standard  deviation  [SD]:  16.0)  and
3.9  mmHg  (95%  CI:  73.2-74.7;  SD:  10.0),  respectively.  Both
BP  and  DBP  were  higher  in  males  (SBP:  130.0  mmHg,  95%
I:  128.8-131.3,  SD:  14.5  and  DBP:  76.0  mmHg,  95%  CI:  75.1-
6.8,  SD:  9.9)  than  in  females  (SBP:  121.0  mmHg,  95%  CI:
19.5-122.6,  SD:  16.1  and  DBP:  72.1  mmHg,  95%  CI:  71.1-
3.2,  SD:  9.7).
The  overall  hypertension  prevalence  was  36.0%  (95%  CI:
4.3-37.7).  A  signiﬁcantly  higher  prevalence  was  observed
n  males  (39.6%,  95%  CI:  36.5-42.8)  than  in  females  (32.7%,
5%  CI:  30.1-35.5).  Prevalence  increased  with  age,  reaching
1.3%  in  the  65-74  age  group.  The  highest  prevalences  were
ound  among  individuals  with  the  ﬁrst  cycle  or  no  formal
ducation,  those  who  had  no  formal  occupation  (student,
etired  or  homemaker)  and  those  who  reported  being  mar-
ied  or  in  a  civil  union  (Table  1).
An  association  was  found  between  hypertension,  male
ender  and  being  married  or  in  a  civil  union,  while  an
ncrease  in  prevalence  was  found  with  age,  lower  educa-
ional  level  and  having  an  occupational  status  other  than
mployed  or  unemployed.
After  adjustment,  the  association  with  age,  education
nd  occupation  decreased  and  no  statistical  association  was
ound  with  marital  status  (Table  2).  Nevertheless,  the  high-
st  aPR  was  observed  among  individuals  aged  between  65
nd  74  years,  who  had  no  or  only  the  ﬁrst  cycle  of  basic
ducation,  males,  and  those  who  had  an  occupational  sta-
us  other  than  employed  or  unemployed  (Table  2).  In  this
ubgroup  (n=214),  the  hypertension  prevalence  was  80.9%
95%  CI:  74.5-85.9).
Given  that  no  effect  modiﬁcation  was  found  related  to
ender,  adjusted  prevalence  ratios  were  not  stratiﬁed  by
ender.
Among  hypertensive  individuals,  69.8%  were  aware  of
heir  condition  and  69.4%  were  under  medical  treatment.
he  proportions  of  individuals  who  were  aware  of  their
ondition  and  who  were  under  medical  treatment  were
igher  among  females  (77.8%  and  78.9%,  respectively)  than
ales  (62.5%  and  60.7%)  and  increased  with  age  in  both
exes  (Table  3).
Of  those  under  medical  treatment,  71.3%  had  optimal
lood  pressure  levels,  and  no  signiﬁcant  differences  were
ound  in  gender  or  age  group  (Table  3).
At  the  population  level  25.0%  (95%  CI:  23.3-26.7)  of
ndividuals  aged  25-74  years  were  taking  antihypertensive
edication.
Overall,  82.2%  of  the  population  aged  25-74  years
eported  having  had  their  blood  pressure  measured  by  a
ealth  professional  in  the  12  months  prior  to  the  interview
nd  almost  half  (46.1%)  reported  having  had  it  measured
n  the  previous  three  months.  The  proportion  of  individu-
ls  whose  blood  pressure  had  been  measured  in  the  three
onths  before  the  interview  increased  with  age  (60.4%  in
he  oldest  age  group)  and  was  higher  among  females  (49.7%).
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Table  1  Prevalence  of  hypertension  according  to  gender,  age  group,  education,  occupation,  marital  status  and  type  of  resi-
dential area.
Characteristics  Total  (n=4910),
%  (95%  CI)
Male  (n=2265),
%  (95%  CI)
Female  (n=2645),
% (95%  CI)
Age  group
25-44  years  12.1  (10.1-14.3)  16.3  (13.7-19.2)  8.1  (5.5-11.7)
45-54 years  35.8  (31.3-40.6)  37.5  (31.1-44.5)  34.3  (29.4-39.5)
55-64 years  58.4  (51.4-65.0)  66.1  (56.8-74.2)  51.5  (44.9-58.1)
65-74 years  71.3  (65.7-76.4)  74.2  (68.5-79.3)  68.9  (61.3-75.7)
Education
None or  1st  cycle  of  basic  education 62.6  (59.4-65.8) 65.6  (61.1-69.8)  60.2  (56.0-64.3)
2nd or  3rd  cycle  of  basic  education 33.4  (29.4-37.6) 34.9  (29.8-40.3) 31.6  (26.4-37.3)
Secondary education 24.0  (21.0-27.4) 29.6  (25.0-34.7) 18.7  (14.7-23.5)
Higher education  15.5  (12.8-18.5)  20.6  (14.4-28.6)  12.3  (9.1-16.5)
Occupation
Employed 24.7  (22.7-26.8)  29.3  (26.3-32.6)  20.0  (17.3-23.1)
Unemployed  30.8  (25.8-36.2)  36.9  (29.8-44.5)  25.6  (19.3-33.1)
Othera 64.5  (60.7-68.0)  69.7  (64.9-74.2)  60.7  (55.3-65.9)
Marital status
Unmarriedb 26.9  (24.0-30.1) 26.5  (21.1-32.7) 27.3  (23.8-31.2)
Married 40.2  (37.7-42.7) 45.5  (40.9-50.1) 35.3  (32.3-38.4)
Type of  residential  area
Rural  38.6  (34.5-42.9)  41.4  (36.6-46.4)  35.9  (30.4-41.7)
Urban 35.1  (33.3-36.9)  38.9  (35.0-42.9)  31.7  (28.7-34.8)
a Student, retired or homemaker.
b Single, divorced, separated or widowed.
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Weighting estimates to account for different selection probabiliti
Only  0.7%  of  all  participants  reported  never  having  had
their  blood  pressure  measured.  Although  the  point  estimate
was  higher  among  male  participants  (1.1%),  no  signiﬁcant
differences  were  found  between  the  sexes  (Table  4).
Discussion
Hypertension  is  a  major  risk  factor  for  cardiovascular  disease
in  the  Portuguese  population,  and  its  prevalence  increases
with  age,  reaching  more  than  70%  of  the  population  aged
65-74  years  in  2015.  In  our  overall  study  population,  36.0%
of  those  aged  between  25  and  74  years  had  hypertension.
Higher  prevalences  were  observed  in  males,  older  individu-
als  (65-74  years),  those  who  had  no  or  only  the  ﬁrst  cycle
of  basic  education,  and  those  with  occupational  status  other
than  employed  or  unemployed.  Regarding  those  classiﬁed  as
having  hypertension,  69.8%  were  aware  of  their  condition,
69.4%  were  under  medical  treatment  and  71.3%  of  treated
individuals  reached  optimal  blood  pressure  levels.
There  is  evidence  that  those  who  do  not  participate
in  health  surveys  are  less  interested  in  their  own  health,
have  less  healthy  behaviors  and  are  less  healthy  than  those
who  agree  to  participate.20--23 As  our  participation  rate
was  43.9%,  potential  differences  between  participants  and
non-participants  could  have  biased  our  results,  most  likely
toward  underestimation  of  the  prevalence  of  hypertension.
However,  self-reported  use  of  antihypertensive  drugs  was
similar  between  participants  (25.0%)  and  non-participants
t
g
h
multing from complex sample design.
26.0%)  (Supplementary  Table  2),  suggesting  that  this  selec-
ion  bias  had  at  most  a  minor  effect  on  our  estimates.  The
act  that  we  followed  the  procedures  recommended  for  the
HES,13,14 performing  a  prior  pilot  study,  training  staff  in
tudy  procedures,  using  comparable  target  populations  and
onitoring  data  quality  during  the  survey,  may  have  helped
o  minimize  misclassiﬁcation  bias.
Compared  to  previous  studies  performed  in  representa-
ive  samples  of  the  Portuguese  population  that  used  direct
lood  pressure  measurements,  a  slightly  lower  hypertension
revalence  was  found  (42.1%  in  the  PAP  study  in  20039 and
2.2%  in  the  PHYSA  study,  2011-1210).  Nevertheless,  when
omparing  hypertension  prevalence  by  age  group  and  gen-
er  between  the  three  studies,  signiﬁcant  differences  were
nly  observed  with  the  PAP  study.9,10 It  cannot  therefore  be
xcluded  that  the  observed  differences  may  derive  to  some
xtent  from  studying  a younger  population  than  that  used  in
revious  studies.
The higher  prevalence  observed  in  males6,9,10 and  in  older
ndividuals6,8--10 was  in  line  with  previous  studies  and  showed
ypertension  to  be  a  major  cardiovascular  risk  factor  in
he  adult  Portuguese  population.  Although  biological  factors
lso  potentially  play  a  part,  the  differences  found  highlight
isparities  in  the  distribution  of  risk  factors  for  hyper-
ension  between  the  sexes  and  between  socioeconomic
roups.  For  instance,  a  higher  prevalence  of  smoking24 and
igher  salt  consumption10 have  been  observed  in  Portuguese
ales.
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Table  2  Crude  and  adjusted  prevalence  ratios  of  hypertension  according  to  gender,  age  group,  education,  occupation,  marital
status and  type  of  residential  area.
Characteristic  PR  95%  CI  aPR  95%  CI
Gender
Female  reference
Male 1.21  1.06-1.38  1.23  1.09-1.39
Age group
25-44  years  reference
45-54 years  2.97  2.49-3.55  2.60  2.19-3.08
55-64 years  4.84  3.75-6.24  3.76  2.95-4.79
65-74 years 5.91  5.02-6.96  4.11  3.52-4.80
Marital status
Unmarrieda reference
Married  1.49  1.29-  1.72  1.07  0.93-1.23
Education
None or  1st  cycle  of  basic  education  4.05  3.34-4.91  1.84  1.51-2.23
2nd or  3rd  cycle  of  basic  education 2.16  1.73-2.71  1.59  1.32-1.91
Secondary education 1.55  1.27-1.90  1.40  1.12-1.76
Higher education reference
Occupation
Employed  reference
Unemployed  1.25  1.05-1.47  0.99  0.84-1.18
Otherb 2.61  2.36-2.89  1.17  1.02-1.34
Type of  residential  area
Rural  reference
Urban 0.90  0.81;  1.03
a Single, divorced, separated or widowed.
b Student, retired or homemaker.
aPR: adjusted prevalence ratio; CI: conﬁdence interval; PR: crude prevalence ratio.
Type of residential area was not included in the multivariate model since it was not signiﬁcant in the bivariate analysis.
Table  3  Proportion  of  awareness,  treatment  and  control  of  hypertension  according  to  age  group  and  gender.
Characteristics  Awareness,  %  (95%  CI)  Medical  treatment,  %  (95%  CI)  Control,  %  (95%  CI)
Overall  69.8  (64.8-74.3) 69.4  (65.2-73.3  71.3  (67.6-74.7
Age group  p<0.001  p<0.001  p=0.1493
25-44 years  44.7  (32.9-57.1)  38.4  (28.1-49.8)  72.7  (60.4-82.4)
45-54 years  53.5  (45.0-61.9)  54.3  (45.7-62.5)  66.7  (58.6-73.9)
55-64 years 79.9  (74.4-84.5)  78.1(73.9-81.8)  75.5  (69.9-80.4)
65-74 years  82.2  (77.9-85.8)  85.0  (81.5-88.0)  69.0  (63.5-74.1)
Gender p<0.001  p<0.001  p=0.0155
Male 62.5  (56.2-68.3)  60.7  (55.5-65.6)  67.2(63.5-70.7)
Female 77.8(71.9-82.7)  78.9  (72.9-83.9)  74.7  (69.3-79.4)
CI: conﬁdence interval.
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Regarding  self-awareness  of  hypertension,  there  was  a
igher  proportion  of  individuals  aware  of  their  condition  in
015  than  in  2003  (69.8%  vs.  45.7%).  However,  compared  to
gures  for  2011-12,  awareness  was  lower  in  2015  (69.8%  vs.
6.6%).  The  same  was  found  regarding  the  proportion  of  indi-
iduals  under  medical  treatment  (INSEF,  2015:  69.4%;  PAP,
003:  38.9%  and  PHYSA,  2011-12:  74.9%).  It  is  important  to
ighlight  the  increase  in  the  number  of  treated  individuals
y
t
i
dsulting from complex sample design.
ho  reached  optimal  blood  pressure  levels  over  the  years
n  all  age  groups  compared  to  previous  studies  (PAP,  2003:
1.2%;  PHYSA,  2011-12:  42.5%;  INSEF,  2015:  71.3%).9,10 How-
ver,  the  target  populations  in  2003  and  2011-12  (age  18-90
ears,  mainland  population  only)  were  not  fully  comparable
o  the  target  population  studied  in  2015  (age  25-74  years,
ncluding  Madeira  and  the  Azores),  which  may  explain  the
ifferences  observed.  Moreover,  the  observed  differences
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Table  4  Distribution  of  the  population  according  to  the  last  blood  pressure  measurement  by  a  health  professional  by  age  group
and gender.
<3  months,  %
(95%  CI)
3-5  months,  %
(95%  CI)
6-11  months,  %
(95%  CI)
≥12  months,  %
(95%  CI)
Never,  %  (95%
CI)
Overall  46.1  (44.3-47.9)  17.1  (15.5-18.8)  19.0  (17.2-21.0)  17.1  (15.4-18.9)  0.7  (0.3-1.3)
Age group
25-44  years  37.3  (35.1-39.5)  16.5  (14.1-19.2)  21.3  (18.5-24.4)  23.8  (20.9-26.9)  1.2  (0.5-2.9)
45-54 years  45.1  (40.4-49.9)  17.1  (14.5-20.1)  20.9  (18.0-24.1)  16.6  (13.1-20.7)  0.3  (0.2-0.4)
55-64 years  54.2  (49.5-58.7)  19.0  (15.6-23.0)  14.4  (12.1-17.0)  12.1  (10.2-14.3)  0.3  (0.3-0.4)
65-74 years  60.4  (54.5-66.1)  16.3  (12.8-20.5)  16.2  (12.9-20.2)  6.7  (5.0-8.8)  0.4  (0.3-0.5)
Gender
Male 42.1  (40.0-44.1) 18.4  (16.3-20.7)  19.0  (17.7-20.3)  19.4  (16.8-22.3)  1.1  (0.5-2.5)
Female 49.7  (47.3-52.2)  15.9  (14.0-18.0)  19.0  (16.3-22.1)  15.0  (12.9-17.4)  0.3  (0.1-0.7)
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Weighting estimates to account for different selection probabiliti
may  still  be  due  to  different  procedures  being  used  for  blood
pressure  measurement  in  each  study.
Although  82.2%  of  the  adult  Portuguese  population  (age
25-74  years)  reported  having  had  their  blood  pressure  mea-
sured  in  the  12  months  preceding  the  interview,  only  69.8%
of  hypertensive  individuals  were  aware  of  their  condition.
This  may  be  explained  by  the  high  hypertension  incidence
observed  in  Portugal,25 but  may  also  indicate  a  low  level  of
understanding  of  their  condition,  particularly  if  no  pharma-
cological  treatment  was  prescribed.
Males  had  their  blood  pressure  measured  less  frequently
and  were  less  likely  to  be  aware  of  their  condition  and  con-
sequently  to  be  under  medical  treatment.  Considering  that
the  highest  hypertension  prevalence  was  observed  in  males,
this  may  indicate  a  misunderstanding  of  the  risk  of  having
high  blood  pressure.
In  addition,  the  lowest  level  of  hypertension  awareness
was  found  in  those  aged  25-44  years,  which  suggests  that
they  had  a  low  perception  of  their  risk.  Although  this  age
group  has  a  lower  incidence  of  hypertension  than  the  other
age  groups,  studies  show  that  hypertension  is  no  longer  an
uncommon  condition  at  younger  ages,  which  is  in  agree-
ment  with  the  increasing  hypertension  incidence  observed
in  young  Portuguese  adults  in  recent  years.25
Our  results  appear  to  be  in  line  with  the  decrease
in  mortality  from  cardiovascular  and  cerebrovascular  dis-
ease  observed  in  Portugal  in  the  last  decade,26 although
this  remains  above  the  average  for  European  Union  coun-
tries.  These  ﬁndings  coincide  with  preventive  measures
implemented  by  the  National  Programs  for  Cerebro-  and
Cardiovascular  Diseases,  Prevention  and  Control  of  Tobacco
Use,  and  Promotion  of  Healthy  Nutrition.  These  measures
include  approval  and  implementation  of  a  national  law  redu-
cing  levels  of  salt  in  bread,  and  entering  into  contracts  with
primary  healthcare  units  to  achieve  speciﬁc  levels  of  con-
trol  in  hypertensive  patients.  Although  the  value  of  some
of  these  preventive  actions  is  well  known,27 it  would  be
useful  to  estimate  their  effect  in  Portugal,  particularly  of
those  related  to  delivery  of  care  and  organization  of  local
services.  Using  national  surveys  to  monitor  hypertension
indicators  (mortality,  incidence,  prevalence  and  control)
T
wulting from complex sample design.
ill  help  to  assess  different  preventive  measures  imple-
ented  over  time.
onclusions
his  study  indicates  that  a  large  majority  of  the  adult  Por-
uguese  population  are  likely  to  reach  blood  pressure  levels
eﬁned  as  hypertension  during  adulthood.  Differences  in
ypertension  prevalence  by  age,  gender  and  socioeconomic
tatus  highlight  the  need  to  implement  wide-population
trategies  that  do  not  increase  heath  inequalities.  Primordial
nd  primary  prevention  strategies  targeting  hypertension
isk  factors  such  as  smoking,  alcohol  consumption,  salt
ntake  and  lack  of  exercise  throughout  life  may  reduce
ypertension  incidence  in  the  future  while  avoiding  health
nequalities.  In  addition,  secondary  and  tertiary  preven-
ion  strategies  are  still  needed,  given  the  high  prevalence
bserved,  and  should  be  directed  at  the  most  affected  popu-
ation  groups  (males,  those  aged  65-74  years  and  those  with
ittle  or  no  formal  education).
unding sources
he  Portuguese  National  Health  Examination  Survey  was
eveloped  as  part  of  the  project  ‘‘Improvement  of  epidemi-
logical  health  information  to  support  public  health  decision
nd  management  in  Portugal.  Towards  reduced  inequali-
ies,  improved  health,  and  bilateral  cooperation’’,  which
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